The in vitro activity of six cathelicidin peptides against 25 strains of Chlamydia was investigated. SMAP-29
proved to be the most active peptide, reducing the inclusion numbers of all 10 strains of Chlamydia trachomatis
tested by >50% at 10 g/ml. This peptide was also active against C. pneumoniae and C. felis.
